Article
Identifying a nasal gene expression signature associated with hyperinflation and treatment response in severe COPD
15 Oct 2020
Abstract excerpt
-agonist (LABA) treatment on both lung function measures of hyperinflation, and the nasal epithelial gene-expression profile in severe COPD. 117 patients were screened and 60 COPD patients entered a 1-month run-in period on low-dose ICS/LABA budesonide/formoterol (BUD/F) 200/6 one inhalation b.i.d. Patients were then randomly assigned to 3-month treatment with either a high dose BDP/F 100/6 two inhalations b.i.d....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
